APOTHEEK WELLENS
0463.599.226 · rovalta.com · 26/09/2026
APOTHEEK WELLENS
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOAPOTHEEK WELLENS is a Private limited company incorporated in 1998. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Herentals. It employs on average 2,4 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0463.599.226
- Incorporation
- 18/06/1998
- Legal form
- Private limited company
- Registered office
- St.-Jobsstraat(HRT) 122
2200 Herentals · Flandre - Contributed capital
- 18 592,01 €
- Latest accounts
- 31/12/2024
- Average workforce
- 2,4 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 19 filingsTrend over 19 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 270,6 k € | -20.9% | 342,2 k € | -5.7% | 363 k € | +62.2% | 223,7 k € | +25.5% | 178,3 k € |
| EBITDA | 138,2 k € | -26.2% | 187,2 k € | -16.3% | 223,6 k € | +58.7% | 140,9 k € | +43.2% | 98,4 k € |
| Operating result | 57,8 k € | -46.3% | 107,7 k € | -28.9% | 151,5 k € | +111% | 71,7 k € | +142% | 29,7 k € |
| Net result | 47,9 k € | -50.4% | 96,5 k € | -34.3% | 146,8 k € | +126% | 65 k € | +195% | 22 k € |
| Balance sheet | |||||||||
| Equity | 465,4 k € | +0.4% | 463,5 k € | +0.5% | 461 k € | +3.8% | 444,2 k € | +17.1% | 379,2 k € |
| Total assets | 1,2 M € | +3.5% | 1,2 M € | -5.6% | 1,2 M € | +15.9% | 1,1 M € | -17.0% | 1,3 M € |
| Cash | 154 k € | -10.4% | 172 k € | -7.4% | 185,7 k € | +31.3% | 141,4 k € | +19.2% | 118,7 k € |
| Debts | 733,6 k € | +5.4% | 696,1 k € | -9.3% | 767,5 k € | +24.5% | 616,4 k € | -31.5% | 899,3 k € |
| Other | |||||||||
| Workforce | 2,4 ETP | -4.0% | 2,5 ETP | 0.0% | 2,5 ETP | +56.2% | 1,6 ETP | 0.0% | 1,6 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/2024Other companies at this address
St.-Jobsstraat(HRT) 122 2200 Herentals| Company | CBE no. |
|---|---|
Welpharma● Active | 0661.922.258 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/08/2025 | 04/07/2024 | 29/06/2023 | 07/07/2022 | 29/06/2021 | 19/05/2020 |
| General meeting | 16/05/2025 | 07/06/2024 | 19/05/2023 | 20/05/2022 | 21/05/2021 | 15/05/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 16/05/2025 | 29/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 07/06/2024 | 04/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 19/05/2023 | 29/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 20/05/2022 | 07/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 21/05/2021 | 29/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 15/05/2020 | 19/05/2020 | Dutch | |
| Abridged model | 31/12/2018 | 17/05/2019 | 14/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 18/05/2018 | 25/05/2018 | Dutch | |
| Abridged model | 31/12/2016 | 19/05/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 21/05/2016 | 23/05/2016 | Dutch | |
| Abridged model | 31/12/2014 | 30/06/2015 | 22/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/06/2014 | 28/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/06/2013 | 29/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 30/06/2012 | 30/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 30/06/2011 | 25/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 11/06/2010 | 17/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 05/06/2009 | 19/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 06/06/2008 | 27/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 08/06/2007 | 05/07/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2024Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202447,9 k €↓
- 2023Annual accounts 202396,5 k €↓
- 2022Annual accounts 2022146,8 k €↑
- 2021Annual accounts 202165 k €↑
- 2020Annual accounts 202022 k €↑
- 2019Annual accounts 2019-13,3 k €↓
- 2018Annual accounts 201847,5 k €↓
- 2017Annual accounts 201774,7 k €↑
- 2016Annual accounts 201659,3 k €↓
- 2015Annual accounts 2015127,8 k €↑
- 2014Annual accounts 2014111,8 k €↓
- 2013Annual accounts 2013128,8 k €↓
- 2012Annual accounts 2012155,2 k €↑
- 2011Annual accounts 201193,8 k €↓
- 2010Annual accounts 2010103 k €↑
- 2009Annual accounts 200973,1 k €↑
- 2008Annual accounts 200845,8 k €↓
- 2007Annual accounts 200798,2 k €↑
- 2006Annual accounts 200672,6 k €
- 18/06/1998IncorporationPrivate limited company